Little evidence that vasectomy raises prostate cancer risk

July 18, 2017

(HealthDay)—For men who have had or might undergo a vasectomy, there is good news: A major study finds scant evidence that the procedure raises their risk of prostate cancer.

"At most, there is a trivial association between vasectomy and that is unlikely to be causal," concluded a team led by Dr. R. Jeffrey Karnes, of the Mayo Clinic in Rochester, Minn.

The analysis, based on data from 53 studies on the subject, was published online July 17 in the journal JAMA Internal Medicine.

As the researchers noted, couples who want to avoid unintended pregnancy often place the responsibility on the female partner. And sometimes, conception occurs despite the use of or devices.

In contrast, vasectomy has a very low risk of . And, "given the lower costs and lower risk of complications for vasectomy compared with [female] tubal ligation, it is clear that vasectomy is underused and should be offered more routinely to couples," the researchers suggested.

Vasectomy is typically a 30-minute outpatient procedure where a local anesthetic is applied to the scrotum and a doctor makes a small incision, pulling out the vas deferens (tubes that transport sperm). These tubes are then either cut or blocked before re-insertion, preventing fertilization.

But one potential reason holding some men back from "the snip" could be fears that it might somehow raise their odds for prostate cancer. According to Karnes and colleagues, those fears were stoked in the 1980s and 1990s by isolated reports of an "association between vasectomy and the risk of prostate cancer."

That initial controversy has died down, however, with better-conducted studies in recent years finding no such link. To try to settle the controversy, the Mayo team pored over data from 53 studies conducted across the world, involving a total of more than 14 million men.

The studies typically compared prostate cancer rates for men of similar ages who'd either had a vasectomy or not. Study follow-up varied from just under 2 years to more than 24 years.

The result? Overall, there was no link at all between vasectomy and the "high-grade" aggressive prostate tumors that are a bigger threat to health. There was a "weak association"—about a 5 percent hike in relative risk—between vasectomy and any form of prostate cancer, but even that statistic might be due to other factors, the study authors said.

As the integrity and methodology of studies got better, any link between vasectomy and prostate cancer shrank to near zero, the investigators noted.

And even if such a link did exist, the researchers calculated it would translate to only a 0.6 percent rise over a lifetime in the absolute risk of prostate cancer for any one man who underwent a vasectomy.

"It is questionable whether such a small increased risk is important to the public," the study authors said.

Dr. David Samadi is chair of urology at Lenox Hill Hospital in New York City. He read the study and offered up an explanation for even the 0.6 percent rise in risk.

The finding "demonstrates the effects of 'health-seeking' activities among men undergoing vasectomy," he said. "Simply put, men who decide to go with vasectomy [tend to] visit physicians more often and get tested for [prostate-specific antigen] and prostate cancer more often than other men. This conscious health-seeking behavior leads to more prostate cancer diagnoses."

The bottom line, according to the Mayo team, is that "although patients should be appropriately counseled, concerns about the risk of prostate cancer should not preclude clinicians from offering vasectomy to couples seeking long-term contraception."

Samadi agreed. The new study "demonstrates that is a safe procedure, which does not increase the chance of in men," he said.

Explore further: Vasectomy may increase risk of aggressive prostate cancer

More information: David Samadi, M.D., chairman, urology & chief, robotic surgery, Lenox Hill Hospital, New York City; July 17, 2017, JAMA Internal Medicine, online

For more on vasectomies, head to the American Academy of Family Physicians.

Related Stories

Vasectomy may increase risk of aggressive prostate cancer

July 9, 2014
Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health (HSPH). The researchers found ...

Vasectomy may not raise prostate cancer risk after all

September 20, 2016
(HealthDay)—A large, new study challenges previous research that suggested vasectomies might increase the risk of prostate cancer or dying from it.

Vasectomy reversal outcomes up with same partner as before

January 9, 2015
(HealthDay)—Fertility outcomes are improved for men who undergo vasectomy reversal and have the same female partner as before vasectomy, according to a study published in the January issue of The Journal of Urology.

Risk factors for prostate cancer

September 30, 2015
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and ...

Risk of all cancers, specific cancers up in infertile men

May 5, 2015
(HealthDay)—Infertile men have increased risk of all cancers and some individual cancers, according to a study published in the May issue of The Journal of Urology.

Body size and prostate cancer risk

July 14, 2017
Prostate cancer is the most common cancer in men in Europe and the second most frequently diagnosed cancer in men worldwide.

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.